EnableComp Acquires Helix Advisory, Advancing Zero Balance Review Technology in Its Complex Revenue Recovery Platform
EnableCompAcquirer
Helix AdvisoryTarget
EnableComp has acquired Cincinnati‑based Helix Advisory, expanding its Zero Balance Review technology within a platform that already recovers roughly $3 billion annually for more than 1,000 hospitals.
EnableComp announced on Aug. 12, 2026 that it has acquired Helix Advisory, a revenue‑recovery specialist, in a deal whose financial terms were not disclosed. The transaction adds a technology layer that uncovers underpayments that traditional, rules‑based audit engines routinely miss, and it brings Helix founder Zack Higbie on board as Vice President of Revenue Recovery Products.
Deal Terms
The acquisition integrates Helix’s three core capabilities—underpayment identification, clinical signal detection, and root‑cause analytics—into EnableComp’s existing Complex Revenue Recovery suite. While the purchase price remains private, the move follows EnableComp’s strategy of consolidating complementary health‑tech SaaS tools to deepen its value‑capture in the hospital revenue cycle market.
Strategic Rationale
Hospital underpayments exceed $130 billion annually from Medicare and Medicaid alone, according to the American Hospital Association. Conventional audit platforms rely on preset thresholds that filter out low‑value or highly complex claims, leaving a sizable revenue gap. Helix’s machine‑learning‑driven engine surfaces those gaps, allowing providers to recover incremental revenue without a separate vendor. EnableComp’s CEO Frank Forte emphasized that the combined platform will let clients “stop leaving money on the table” by handling even the smallest, most complex claims natively.
Operational Impact
EnableComp currently supports over 1,000 hospitals and processes roughly $3 billion in recoveries each year across its Complex Claims, Complex Denials, and Complex Revenue Recovery solutions. Early Helix customers have reported net revenue improvements exceeding 2 % on previously unrecognized amounts. By embedding this capability, EnableComp expects to boost overall recovery rates, improve client retention, and differentiate its platform from competing RCM vendors that still rely on legacy audit logic.
The integration is already underway, with engineering teams working to fuse Helix’s analytics into the broader EnableComp workflow. The combined offering positions the company as a one‑stop shop for end‑to‑end revenue integrity, potentially raising the ceiling for upsell and cross‑sell opportunities within its existing hospital base.
Why It Matters
For EnableComp, the acquisition eliminates the need to partner with or acquire a separate audit vendor, tightening its end‑to‑end revenue cycle stack and creating a defensible moat around underpayment recovery. Competitors that continue to rely on rule‑based engines may find it harder to retain hospitals seeking deeper, data‑driven insights, prompting a wave of product upgrades or similar bolt‑on deals. Helix Advisory gains immediate scale, access to a national client base, and the resources to accelerate product development, while its founder’s move into an executive role ensures continuity of expertise.
The deal also reshapes the health‑tech SaaS competitive set by raising the bar for what constitutes a complete RCM solution. Vendors that cannot match the combined analytics and clinical signal detection may need to explore partnerships or risk losing market share to EnableComp’s expanded platform, especially as hospitals intensify focus on margin recovery amid tightening reimbursement environments.
Key Points
- EnableComp acquired Helix Advisory; deal value was not disclosed
- Helix’s technology adds Zero Balance Review capabilities that detect underpayments missed by traditional audit rules
- Helix founder Zack Higbie joins EnableComp as VP of Revenue Recovery Products
- EnableComp serves over 1,000 hospitals and recovers roughly $3 billion annually
- Early Helix clients have seen net revenue improvements of more than 2 %
Analysis
The acquisition underscores a growing trend in health‑tech SaaS: consolidating niche analytics into broader revenue cycle platforms to capture incremental payer dollars. While the purchase price was undisclosed, comparable health‑tech deals have commanded 8‑12× forward ARR, suggesting EnableComp likely paid a premium for Helix’s proprietary machine‑learning models and its early‑stage client traction. For investors, the move signals confidence that underpayment recovery remains a high‑margin, low‑competition niche where software can deliver outsized ROI. Operators can expect tighter integration of claim‑level analytics, reducing reliance on third‑party audit firms and potentially lowering overall RCM costs. As hospitals face sustained pressure on margins, platforms that can surface even sub‑threshold revenue will become essential, prompting further M&A activity as larger players seek to embed similar intelligence. The deal also highlights the importance of cross‑functional talent—Helix’s founder joining as an executive ensures continuity and accelerates product rollout, a model that may become standard in future health‑tech consolidations.